Sanofi-Aventis To Appeal Lovenox Verdict

Law360, New York (February 13, 2007, 12:00 AM EST) -- Sanofi-Aventis will appeal a district court's ruling that its patent for anti-clotting drug Lovenox is unenforceable, Sanofi-Aventis' chief executive said Tuesday.

Sanofi-Aventis' patent infringement lawsuit against generic drug makers Amphastar Pharmaceuticals Inc. and Teva Pharmaceuticals USA Inc. was dismissed on Feb. 9. U.S. District Court Judge Mariana R. Pfaelzer ruled that Sanofi-Aventis was deceptive when it applied for its patent of the drug.

“We will strongly defend this patent and we will appeal,” Sanofi-Aventis Chief Executive Officer Gerard Le Fur said at an analysts’ meeting Tuesday....
To view the full article, register now.